TapewireFind a company

person · Reporting owner

Jasinski Lawrence J

Disclosed activity across 2 companies

Tapewire entity
41066
SEC CIK
0001366346

Export transaction history ↓

Reported relationships

Latest disclosed role at each company.

CompanyLast reported asReport datePublished
LEMAITRE VASCULAR INCLMAT · Entity 1927DirectorSeptember 03, 2026September 08, 2026
Lifeward Ltd.LFWD · Entity 7620Director · Chief Executive OfficerMay 21, 2025May 22, 2025

Disclosed balances

About these balances

Latest available filing per company, not a reconstructed current portfolio. Matching sequences show the last reported balance with all source rows expandable; grouping alone does not establish account ownership. Do not add unresolved positions together. Filings may omit unchanged positions, and amendments may correct only part of an older disclosure. Jointly reported shares are not necessarily this owner's personal holdings.

LEMAITRE VASCULAR INC

Report date September 03, 2026 · Filed September 08, 2026

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Dividend Equivalent RightsSEC Table II · derivative / convertible securityDirect5.6103 Reported balance After 2026-09-03 transaction · row 1 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 1 · 2026-09-03 · Grant · Acquired 0.5429 · Balance 5.6103

F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Dividend Equivalent RightsSEC Table II · derivative / convertible securityDirect5.5195 Reported balance After 2026-09-03 transaction · row 2 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 2 · 2026-09-03 · Grant · Acquired 0.6503 · Balance 5.5195

F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Dividend Equivalent RightsSEC Table II · derivative / convertible securityDirect5.1836 Reported balance After 2026-09-03 transaction · row 3 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 3 · 2026-09-03 · Grant · Acquired 0.8852 · Balance 5.1836

F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Dividend Equivalent RightsSEC Table II · derivative / convertible securityDirect5.486 Reported balance After 2026-09-03 transaction · row 4 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 4 · 2026-09-03 · Grant · Acquired 1.0022 · Balance 5.486

F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Dividend Equivalent RightsSEC Table II · derivative / convertible securityDirect4.2988 Reported balance After 2026-09-03 transaction · row 5 Instrument identity requires review; Table II rows are not merged.
1 source row

Row 5 · 2026-09-03 · Grant · Acquired 1.6637 · Balance 4.2988

F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Filing footnotes · ownership attribution and instrument terms

F1: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2: These dividend equivalent rights accrued on a performance share unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4: These dividend equivalent rights accrued on a performance share unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/10/2025 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Lifeward Ltd.

Report date May 21, 2025 · Filed May 22, 2025

Security / awardOwnership accountDisclosed shares / unitsDisclosure context
Ordinary Shares, par value NIS 1.75 per shareSEC Table I · non-derivativeIndirectESOP98,728 Reported balance After 2025-05-21 transaction · row 1 Account identity is unresolved; indirect or unspecified ownership is not merged.
1 source row

Row 1 · 2025-05-21 · Sale · Disposed 1,909 · Balance 98,728

F1: Represents Ordinary Shares sold in the open market on May 21, 2025, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting, on May 21, 2025, of certain restricted stock units ("RSUs") previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan on May 21, 2021 (the "Grant Date"). The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between the Reporting Person and Lifeward Ltd. (the "Company") and does not represent a discretionary trade by the Reporting Person.

Ordinary Shares, par value NIS 1.75 per shareSEC Table I · non-derivativeDirect2,142 Reported balance Holding disclosure · report date 2025-05-21 · row 2 Holding and transaction disclosures are not merged.
1 source row

Row 2 · Balance 2,142

Filing footnotes · ownership attribution and instrument terms

F1: Represents Ordinary Shares sold in the open market on May 21, 2025, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting, on May 21, 2025, of certain restricted stock units ("RSUs") previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan on May 21, 2021 (the "Grant Date"). The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between the Reporting Person and Lifeward Ltd. (the "Company") and does not represent a discretionary trade by the Reporting Person.

Transaction history

JSON API
Reset

Purchases/sales include open-market and private transactions. Plan disclosure applies to the filing; individual rows may differ. “Not disclosed” is not “unplanned.”

The cutoff filters transaction history only. Company summaries and owner relationships show the latest available disclosures. Parser corrections can improve historical records.

Transaction dateCompanyActivity / securityShares / unitsReported priceReported valueDetails
May 29, 2025 Filed Jun 2, 2025 20:23 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.8524 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-019165 · rdgdoc.xml · derivative · entry 3

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4.6837

Underlying: Common Stock · 0.8524 shares

Expires not disclosed

F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:23 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.4985 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-019165 · rdgdoc.xml · derivative · entry 2

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5.1096

Underlying: Common Stock · 0.4985 shares

Expires not disclosed

F2 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
May 29, 2025 Filed Jun 2, 2025 20:23 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.4985 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-019165 · rdgdoc.xml · derivative · entry 1

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6.0983

Underlying: Common Stock · 0.4985 shares

Expires not disclosed

F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
May 21, 2025 Filed May 22, 2025 20:29 UTC Lifeward Ltd. LFWD · Entity 7620 SaleOrdinary Shares, par value NIS 1.75 per share 1,909 $1.26 $2,405.34
Disclosure

SEC source: 0001062993-25-010097 · form4.xml · nonDerivative · entry 1

Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · ESOP

Disclosed balance after: 98,728

F1 · shares: Represents Ordinary Shares sold in the open market on May 21, 2025, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting, on May 21, 2025, of certain restricted stock units ("RSUs") previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan on May 21, 2021 (the "Grant Date"). The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between the Reporting Person and Lifeward Ltd. (the "Company") and does not represent a discretionary trade by the Reporting Person.

Read SEC document
March 27, 2025 Filed Mar 31, 2025 21:25 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 1.001 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-010286 · rdgdoc.xml · derivative · entry 5

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1.001

Underlying: Common Stock · 1.001 shares

Expires not disclosed

F5 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F5 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/6/2024 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
March 27, 2025 Filed Mar 31, 2025 21:25 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.9838 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-010286 · rdgdoc.xml · derivative · entry 4

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3.9937

Underlying: Common Stock · 0.9838 shares

Expires not disclosed

F4 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
March 27, 2025 Filed Mar 31, 2025 21:25 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.8214 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-010286 · rdgdoc.xml · derivative · entry 3

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3.8313

Underlying: Common Stock · 0.8214 shares

Expires not disclosed

F3 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
March 27, 2025 Filed Mar 31, 2025 21:25 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.4803 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-010286 · rdgdoc.xml · derivative · entry 2

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4.6111

Underlying: Common Stock · 0.4803 shares

Expires not disclosed

F2 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
March 27, 2025 Filed Mar 31, 2025 21:25 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.4803 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-010286 · rdgdoc.xml · derivative · entry 1

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5.5998

Underlying: Common Stock · 0.4803 shares

Expires not disclosed

F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
March 04, 2025 Filed Mar 6, 2025 22:16 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 SaleCommon Stock 3,142 $92.00 $289,064.00
Disclosure

SEC source: 0001437749-25-006482 · rdgdoc.xml · nonDerivative · entry 1

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,607

Read SEC document
February 28, 2025 Filed Mar 5, 2025 00:20 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionDividend Equivalent Rights · Derivative 1 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-006159 · rdgdoc.xml · derivative · entry 3

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3.0099

Underlying: Common Stock · 1 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · shares: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
February 28, 2025 Filed Mar 5, 2025 00:20 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionCommon Stock 1 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-006159 · rdgdoc.xml · nonDerivative · entry 2

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,749

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

Read SEC document
February 28, 2025 Filed Mar 5, 2025 00:20 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantCommon Stock 204 $0.00 $0.00
Disclosure

SEC source: 0001437749-25-006159 · rdgdoc.xml · nonDerivative · entry 1

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,748

F1 · shares: These shares represent LMAT common stock acquired on February 28, 2025, upon settlement of a Performance Share Unit (PSU) award granted on December 8, 2023. The PSU award vests as follows: 1/3 upon determination by the Compensation Committee and the balance vests in equal annual installments from the grant date over the next two years.

F2 · price: Each PSU represents a contingent right to receive one share of common stock upon vesting based on the attainment of performance goals.

Read SEC document
December 12, 2024 Filed Dec 13, 2024 23:01 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionDividend Equivalent Rights · Derivative 3 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-037504 · rdgdoc.xml · derivative · entry 6

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4.1308

Underlying: Common Stock · 3 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a performance stock unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · shares: These dividend equivalent rights were released in connection with the vesting of a performance stock unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a performance stock unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 12, 2024 Filed Dec 13, 2024 23:01 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionDividend Equivalent Rights · Derivative 3 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-037504 · rdgdoc.xml · derivative · entry 5

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5.1195

Underlying: Common Stock · 3 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 12, 2024 Filed Dec 13, 2024 23:01 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionCommon Stock 3 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-037504 · rdgdoc.xml · nonDerivative · entry 3

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,544

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

Read SEC document
December 12, 2024 Filed Dec 13, 2024 23:01 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionCommon Stock 3 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-037504 · rdgdoc.xml · nonDerivative · entry 2

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,541

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

Read SEC document
December 11, 2024 Filed Dec 13, 2024 23:01 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionDividend Equivalent Rights · Derivative 6 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-037504 · rdgdoc.xml · derivative · entry 4

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1.9846

Underlying: Common Stock · 6 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 11, 2021. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 11, 2024 Filed Dec 13, 2024 23:01 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionCommon Stock 6 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-037504 · rdgdoc.xml · nonDerivative · entry 1

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,538

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

Read SEC document
December 09, 2024 Filed Dec 12, 2024 02:17 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionDividend Equivalent Rights · Derivative 1 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-037272 · rdgdoc.xml · derivative · entry 2

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3.0099

Underlying: Common Stock · 1 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F2 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 8, 2023. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 09, 2024 Filed Dec 12, 2024 02:17 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionCommon Stock 1 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-037272 · rdgdoc.xml · nonDerivative · entry 1

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,532

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

Read SEC document
December 06, 2024 Filed Dec 10, 2024 22:26 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantStock Option (Right to Buy) · Derivative 2,594 $0.00 Strike: $101.12 $0.00
Disclosure

SEC source: 0001437749-24-037138 · rdgdoc.xml · derivative · entry 2

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2,594

Underlying: Common Stock · 2,594 shares

Expires 2029-12-06

F2 · derivative.exercise_date: This option is exercisable and vests over a three-year period at a rate of 33 1/3% on the first anniversary of the date listed in the table, with the balance vesting in equal annual installments over the remaining two years.

Read SEC document
December 06, 2024 Filed Dec 10, 2024 22:26 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantCommon Stock 420 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-037138 · rdgdoc.xml · nonDerivative · entry 1

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,531

F1 · shares: Represents a restricted stock unit award that vests on a time-based schedule as follows: 33 1/3% of the award vests on the anniversary of the grant date listed in the table, with the balance vesting in equal annual installments over the remaining two years.

Read SEC document
December 05, 2024 Filed Dec 10, 2024 00:10 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.8043 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-037038 · rdgdoc.xml · derivative · entry 4

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4.0099

Underlying: Common Stock · 0.8043 shares

Expires not disclosed

F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 05, 2024 Filed Dec 10, 2024 00:10 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.6284 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-037038 · rdgdoc.xml · derivative · entry 3

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7.1308

Underlying: Common Stock · 0.6284 shares

Expires not disclosed

F3 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 05, 2024 Filed Dec 10, 2024 00:10 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.6284 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-037038 · rdgdoc.xml · derivative · entry 2

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 8.1195

Underlying: Common Stock · 0.6284 shares

Expires not disclosed

F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 05, 2024 Filed Dec 10, 2024 00:10 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.3103 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-037038 · rdgdoc.xml · derivative · entry 1

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7.9846

Underlying: Common Stock · 0.3103 shares

Expires not disclosed

F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
November 20, 2024 Filed Nov 22, 2024 21:22 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 SaleCommon Stock 198 $103.50 $20,493.00
Disclosure

SEC source: 0001437749-24-036053 · rdgdoc.xml · nonDerivative · entry 1

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,111

Read SEC document
September 13, 2024 Filed Sep 16, 2024 21:34 UTC Lifeward Ltd. LFWD · Entity 7620 SaleOrdinary Shares, par value NIS 1.75 per share 2,672 $3.26 $8,700.03
Disclosure

SEC source: 0001062993-24-016656 · form4.xml · nonDerivative · entry 1

Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · ESOP

Disclosed balance after: 100,637

F1 · shares: Represents Ordinary Shares sold in the open market on September 13, 2024, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting, on September 13, 2024, of certain restricted stock units ("RSUs") previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan on September 13, 2023 (the "Grant Date"). The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between the Reporting Person and Lifeward Ltd. (the "Company") and does not represent a discretionary trade by the Reporting Person.

F2 · price: Reflects the weighted average sale price for Ordinary Shares sold. Actual sale prices for the shares sold ranged from $3.16 to $3.31. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price.

Read SEC document
August 29, 2024 Filed Sep 3, 2024 23:56 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.9285 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-028309 · rdgdoc.xml · derivative · entry 4

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3.2056

Underlying: Common Stock · 0.9285 shares

Expires not disclosed

F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
August 29, 2024 Filed Sep 3, 2024 23:56 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.7254 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-028309 · rdgdoc.xml · derivative · entry 3

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6.5024

Underlying: Common Stock · 0.7254 shares

Expires not disclosed

F3 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
August 29, 2024 Filed Sep 3, 2024 23:56 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.7254 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-028309 · rdgdoc.xml · derivative · entry 2

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7.4911

Underlying: Common Stock · 0.7254 shares

Expires not disclosed

F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
August 29, 2024 Filed Sep 3, 2024 23:56 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.358 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-028309 · rdgdoc.xml · derivative · entry 1

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7.6743

Underlying: Common Stock · 0.358 shares

Expires not disclosed

F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
August 02, 2024 Filed Aug 6, 2024 13:07 UTC Lifeward Ltd. LFWD · Entity 7620 SaleOrdinary Shares, par value NIS 1.75 per share 2,665 $3.84 $10,233.60
Disclosure

SEC source: 0001062993-24-014477 · form4.xml · nonDerivative · entry 1

Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · ESOP

Disclosed balance after: 103,309

F1 · shares: Represents Ordinary Shares sold in the open market on August 2, 2024, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting, on August 2, 2024, of certain restricted stock units ("RSUs") previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan on August 2, 2022 (the "Grant Date"). The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between the Reporting Person and ReWalk Robotics Ltd. (the "Company") and does not represent a discretionary trade by the Reporting Person.

F2 · price: Reflects the weighted average sale price for Ordinary Shares sold. Actual sale prices for the shares sold ranged from $3.73 to $4.29. The Reporting Person undertakes to provide the Company, any security holder of the Company or the staff of the Securities and Exchange Commission full information regarding the number of shares sold at each separate price.

Read SEC document
June 18, 2024 Filed Jun 21, 2024 12:47 UTC Lifeward Ltd. LFWD · Entity 7620 SaleOrdinary Shares, par value NIS 1.75 per share 3,466 $4.22 $14,617.16
Disclosure

SEC source: 0001062993-24-012855 · form4.xml · nonDerivative · entry 1

Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · ESOP

Disclosed balance after: 105,974

F1 · shares: Represents Ordinary Shares sold in the open market on June 18, 2024, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting, on June 18, 2024, of certain restricted stock units ("RSUs") previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan on June 18, 2020 (the "Grant Date"). The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between the Reporting Person and ReWalk Robotics Ltd. (the "Company") and does not represent a discretionary trade by the Reporting Person.

Read SEC document
May 30, 2024 Filed Jun 3, 2024 21:20 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 1.0426 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-019075 · rdgdoc.xml · derivative · entry 4

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 2.2771

Underlying: Common Stock · 1.0426 shares

Expires not disclosed

F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
May 30, 2024 Filed Jun 3, 2024 21:20 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.8146 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-019075 · rdgdoc.xml · derivative · entry 3

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5.777

Underlying: Common Stock · 0.8146 shares

Expires not disclosed

F3 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
May 30, 2024 Filed Jun 3, 2024 21:20 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.8146 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-019075 · rdgdoc.xml · derivative · entry 2

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6.7657

Underlying: Common Stock · 0.8146 shares

Expires not disclosed

F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
May 30, 2024 Filed Jun 3, 2024 21:20 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.402 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-019075 · rdgdoc.xml · derivative · entry 1

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 7.3163

Underlying: Common Stock · 0.402 shares

Expires not disclosed

F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
May 21, 2024 Filed May 24, 2024 00:24 UTC Lifeward Ltd. LFWD · Entity 7620 SaleOrdinary Shares, par value NIS 1.75 per share 1,620 $4.91 $7,954.20
Disclosure

SEC source: 0001062993-24-011113 · form4.xml · nonDerivative · entry 1

Jasinski Lawrence J · CIK 0001366346 · Director · Chief Executive Officer

10b5-1 filing: No plan indicated

Ownership: Indirect · ESOP

Disclosed balance after: 109,440

F1 · shares: Represents Ordinary Shares sold in the open market on May 21, 2024, in order to satisfy the Reporting Person's tax withholding obligation in connection with the vesting, on May 21, 2024, of certain restricted stock units ("RSUs") previously granted to the Reporting Person under the ReWalk 2014 Equity Incentive Plan on May 21, 2021 (the "Grant Date"). The Ordinary Shares were sold pursuant to an automatic sell-to-cover arrangement between the Reporting Person and ReWalk Robotics Ltd. (the "Company") and does not represent a discretionary trade by the Reporting Person.

F2 · balance_after: The reported number of shares has been adjusted to reflect the impact of the Company's 1-for-7 reverse share split, which became effective on March 15, 2024.

Read SEC document
March 28, 2024 Filed Apr 1, 2024 21:28 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 1.2345 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-010432 · rdgdoc.xml · derivative · entry 4

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 1.2345

Underlying: Common Stock · 1.2345 shares

Expires not disclosed

F4 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/8/2023 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
March 28, 2024 Filed Apr 1, 2024 21:28 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.9644 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-010432 · rdgdoc.xml · derivative · entry 3

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4.9624

Underlying: Common Stock · 0.9644 shares

Expires not disclosed

F3 · derivative.exercise_price: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.exercise_date: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.expiration_date: These dividend equivalent rights accrued on a Performance Stock Unit (PSU) award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
March 28, 2024 Filed Apr 1, 2024 21:28 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.9644 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-010432 · rdgdoc.xml · derivative · entry 2

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5.9511

Underlying: Common Stock · 0.9644 shares

Expires not disclosed

F2 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F2 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/12/2022 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
March 28, 2024 Filed Apr 1, 2024 21:28 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantDividend Equivalent Rights · Derivative 0.476 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-010432 · rdgdoc.xml · derivative · entry 1

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 6.9143

Underlying: Common Stock · 0.476 shares

Expires not disclosed

F1 · derivative.exercise_price: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F1 · derivative.exercise_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F1 · derivative.expiration_date: These dividend equivalent rights accrued on a restricted stock unit award granted on 12/11/2021 and vest proportionately with such award. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
March 05, 2024 Filed Mar 7, 2024 22:20 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 SaleCommon Stock 5,110 $67.50 $344,925.00
Disclosure

SEC source: 0001437749-24-007006 · rdgdoc.xml · nonDerivative · entry 1

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 5,309

Read SEC document
February 29, 2024 Filed Mar 5, 2024 02:20 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionDividend Equivalent Rights · Derivative 1.9887 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-006515 · rdgdoc.xml · derivative · entry 3

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 3.998

Underlying: Common Stock · 1.9887 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F4 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · shares: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F4 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a performance share unit (PSU) award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
February 29, 2024 Filed Mar 5, 2024 02:20 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionCommon Stock 1 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-006515 · rdgdoc.xml · nonDerivative · entry 2

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,419

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

Read SEC document
February 29, 2024 Filed Mar 5, 2024 02:20 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 GrantCommon Stock 593 $0.00 $0.00
Disclosure

SEC source: 0001437749-24-006515 · rdgdoc.xml · nonDerivative · entry 1

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 10,418

F1 · shares: These shares represent LMAT common stock acquired on February 29, 2024, upon settlement of a Performance Share Unit (PSU) award granted on December 12, 2022. The PSU award vests as follows: 1/3 upon determination by the Compensation Committee and the balance vests in equal annual installments from the grant date over the next two years.

F2 · price: Each PSU represents a contingent right to receive one share of common stock upon vesting based on the attainment of performance goals.

Read SEC document
December 12, 2023 Filed Dec 13, 2023 22:05 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionDividend Equivalent Rights · Derivative 1 $0.00 $0.00
Disclosure

SEC source: 0001437749-23-034356 · rdgdoc.xml · derivative · entry 4

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 4.9867

Underlying: Common Stock · 1 shares

Expires not disclosed

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F3 · derivative.exercise_price: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · shares: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.exercise_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

F3 · derivative.expiration_date: These dividend equivalent rights were released in connection with the vesting of a restricted stock unit award granted on December 12, 2022. Each dividend equivalent right is the economic equivalent of one share of the Issuer's common stock.

Read SEC document
December 12, 2023 Filed Dec 13, 2023 22:05 UTC LEMAITRE VASCULAR INC LMAT · Entity 1927 Exercise / conversionCommon Stock 1 $0.00 $0.00
Disclosure

SEC source: 0001437749-23-034356 · rdgdoc.xml · nonDerivative · entry 2

Jasinski Lawrence J · CIK 0001366346 · Director

10b5-1 filing: No plan indicated

Ownership: Direct

Disclosed balance after: 9,825

Exercise/conversion can include RSU settlement. Transaction price and option strike are different fields; a missing price is not zero. Derivative and underlying rows can describe the same event.

F1 · shares: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

F1 · price: Represents shares acquired upon release of dividend equivalent rights, as reported in Table II, on a one-for-one basis.

Read SEC document

Value uses the disclosed total when available, otherwise shares × reported transaction price. It is not an estimate of exercise cash cost or investment performance.